Thu, Oct 2, 2014, 8:03 AM EDT - U.S. Markets open in 1 hr 27 mins

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • goingreen11 goingreen11 Jan 26, 2013 9:53 PM Flag

    Hey racavalli Have a question for you

    Why couldn't the CEO be more positive about Zertane or at least more understanding of what investors need to hear especially if ampe is shopping for a partner, Dosen`t make any sense what they said at the conference and aren't the zertane trials taking place outside the US and looking for European approval only at this point ?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • All the Zertane trials to date were done in Europe. The FDA did not accept the European trials for approval in the USA. Ampio has applied for a phase III trial in the US and are awaiting approval of that trial. My take on the CEO's remarks about Zertane is that they have a partner that will take Zertane through US Phase III once the trial is approved

      Sentiment: Strong Buy

    • My understanding is that the final phase III trial has already been completed and that they are only waiting for the FDA's response. I believe these trials took place in the U.S. recently.

      They are looking U.S. approval and some other foreign countries.

      I think we will hear very soon!

      Sentiment: Strong Buy

      • 2 Replies to racavalli
      • I thought it was funny when you wrote in a previous post "I have done more due diligence on this company then even the analyst at Aegis", especially when you now write "My understanding is that the final phase III trial has already been completed and that they are only waiting for the FDA's response. I believe these trials took place in the U.S. recently."

        Do you understand that all clinical studies in the US as listed on the FDA clin trials dot gov site? Are any of AMPE's studies listed there? Hmmmmm.

        Did you eve read AMPE's June 21 press release, which said "The FDA provided all the necessary guidance on the design and conduct of two concurrent phase III pivotal clinical trials of approximately 15 weeks duration."? Do you think AMPE just snuck those in?

        Also, AMPE stated in the December investor presentation for Zertane "two concurrent
        Phase III pivotal trials set to begin enrollment in 1Q13". Did you miss this?

      • If you listen carefully to the investor presentation they said they are waiting for FDA approval to start Zertane's "pivotal trial". Why makes you think the Phase 3 trial has already been completed?

    • One more investor presentation like the last one by the CEO & stock will be at $3.00. Inexcusable for him to be so vague about Zertane. The only take away is that they will not be able to monetize it.

 
AMPE
3.56+0.03(+0.85%)Oct 1 4:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.